Janux Therapeutics, Inc. (JANX) Social Stream



Janux Therapeutics, Inc. (JANX): $50.55

1.31 (-2.53%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add JANX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#116 of 362

in industry

JANUX THERAPEUTICS INC (JANX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering JANUX THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 3 $35 $35 $35 $10.31 239.48%
2022-09-17 2 $35 $29 $32 $10.31 210.38%
2023-03-13 3 $35 $29 $32 $10.31 210.38%
2023-03-17 4 $35 $26 $30.5 $10.31 195.83%
2023-06-06 4 $35 $24 $28.333 $10.31 174.81%
2023-11-08 4 $35 $24 $28 $10.31 171.58%
2023-11-13 5 $35 $21 $26.666 $10.31 158.64%

The Trend in the Analyst Price Target


Over the past 17 months, JANX's average price target has gone down $5.33.

Over the past 41 weeks, JANX's average upside potential has been 147.13%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 3 35 29 32.000 19.74 62.11%
2023-03-13 3 35 29 32.000 13.76 132.56%
2023-04-06 4 35 24 28.333 13.42 111.13%
2023-05-10 4 35 24 28.333 13.86 104.42%
2023-08-11 4 35 24 28.000 12.58 122.58%

JANX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 43 weeks, JANX's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, JANUX THERAPEUTICS INC's number of analysts covering the stock is greater than 106.09% of them.
  • To contextualize these metrics, consider that out of all US stocks, JANUX THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 867.04% of them.
  • JANUX THERAPEUTICS INC's variance in analysts' estimates is lower than -91.52% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, JANUX THERAPEUTICS INC's average analyst price target is greater than 728.49% of them.

Stocks similar to JANUX THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IMRX, RANI, and CYBN.

Make investment decisions regarding JANX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!